Ambroxol mitigates cyclophosphamide-induced liver injury by suppressing TLR-4/NF-κB signaling and oxidative stress and upregulating cytoglobin, TXNRD1 and HMGB1

doi:10.3748/wjg.v31.i35.108139

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 35

This Article

(42)

(48)

(0)

(13)

(1084)

(3)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Sep 21, 2025; 31(35): 108139
Published online Sep 21, 2025. doi: 10.3748/wjg.v31.i35.108139

Full Size Figure Download Figure

Figure 1 Ambroxol ameliorated liver function markers in cyclophosphamide-administered rats. A: Serum alanine aminotransferase; B: Aspartate aminotransferase; C: Alkaline phosphatase; D: Albumin. Data are expressed as mean ± SD (n = 6). ^aP < 0.05 and ^cP < 0.001 vs control group. ^fP < 0.001 vs cyclophosphamide. ABX: Ambroxol; CP: Cyclophosphamide; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; ALP: Alkaline phosphatase.

Citation: Alruhaimi RS, Hassanein EHM, Alnasser SM, Ahmeda AF, Althagafy HS, Abd El-Ghafar OAM, Mahmoud AM. Ambroxol mitigates cyclophosphamide-induced liver injury by suppressing TLR-4/NF-κB signaling and oxidative stress and upregulating cytoglobin, TXNRD1 and HMGB1. World J Gastroenterol 2025; 31(35): 108139
URL: https://www.wjgnet.com/1007-9327/full/v31/i35/108139.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i35.108139

Alruhaimi RS, Hassanein EHM, Alnasser SM, Ahmeda AF, Althagafy HS, Abd El-Ghafar OAM, Mahmoud AM. Ambroxol mitigates cyclophosphamide-induced liver injury by suppressing TLR-4/NF-κB signaling and oxidative stress and upregulating cytoglobin, TXNRD1 and HMGB1. World J Gastroenterol 2025; 31(35): 108139 [PMID: 41024762 DOI: 10.3748/wjg.v31.i35.108139]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.